Physician profile
Ana Markovic
NPI 1356322143
$779.94
in general payments reported to CMS, 2019-2025
16 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $33.61 · 2021: $14.10 · 2023: $52.74 · 2024: $109 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $221.76 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Pfizer INC. | $114.98 | 2019 | |
| Kaleo, INC. | $62.82 | 2019 | |
| Ironshore Pharmaceuticals INC. | $61.52 | 2019 | |
| Novo Nordisk INC | $58.01 | 2024-2025 | Wegovy, Saxenda, Rybelsus |
| Cranial Technologies, INC | $50.78 | 2019-2020 | |
| Inspire Medical Systems, INC. | $36.70 | 2025 | Inspire |
| Alk-Abello, INC | $28.13 | 2025 | Neffy |
| Ars Pharmaceuticals Operations, INC. | $25.91 | 2025 | Neffy |
| Shire North American Group INC | $20.69 | 2019 | |
| Abbvie INC. | $19.60 | 2025 | |
| Sobi, INC | $19.16 | 2020 | |
| Lilly USA, LLC | $17.99 | 2025 | Zepbound |
| Sanofi Pasteur INC. | $14.41 | 2019 | |
| Eisai INC. | $14.10 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $13.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Markovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.